sort by
approximate search
1shortlisttitle datasearch history  
results search [or] ISN:0000000043641909 | 1 hits
Person
ISNI: 
0000 0000 4364 1909
Name: 
Alan Garber (American academic administrator)
Garber, A. M.
Garber, Alan
Garber, Alan M.
Garber, Alan Michael
Creation class: 
article
Language material
Text
txt
Creation role: 
author
Related names: 
Bhattacharya, Jay
Bhattacharya, Jayanta
Cutler, David M.
Goldhaber-Fiebert, Jeremy D.
Harvard Kennedy School (isMemberOf)
Jones, Charles Irving
MacClellan, Mark B.
MaCurdy, Thomas
MaCurdy, Thomas E.
McClellan, Mark C.
National Bureau of Economic Research Affiliation (see also from)
Newhouse, Joseph P.
Romer, Paul M.
Skinner, Jonathan S.
United States. Congress. Office of Technology Assessment. Health Program
Titles: 
27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 6. Cost effectiveness of assessment and management of risk factors.
Advances in cost-effectiveness analysis of health interventions
Alglucerase for Gaucher's disease: dose, costs and benefits.
Antibiotic exposure and resistance in mixed bacterial populations.
Articles on diagnostic tests: A new series and an invitation to authors
B type natriuretic peptide testing was more cost effective than conventional diagnosis in patients with acute dyspnoea.
Can technology assessment control health spending?
Case mix, costs, and outcomes. Differences between faculty and community services in a university hospital.
Cause-specific mortality among medicare enrollees
Cholesterol screening guidelines: Consensus, evidence, and common sense
Cholesterol screening in asymptomatic adults, revisited. Part 2.
Cholesterol screening in children and adolescents
Cholesterol screening should be targeted.
Combining text classification and Hidden Markov Modeling techniques for categorizing sentences in randomized clinical trial abstracts.
Commentary : The Impact of Medicare Coverage Policies on Health Care Utilization
Committing to exercise : contract design for virtuous habit formation
Comparative Effectiveness Research: Priorities, Methods and Impact
computer program for statistically-based decision analysis., A
concise review of the cost-effectiveness of coronary heart disease prevention., A
Confirmatory Trial in Comparative-Effectiveness Research, The
Consequences of health trends and medical innovation for the future elderly.
Corporate Treatment for the Ills of Academic Medicine
Correction to mikels et Al. (2010).
Cost and effectiveness of cholesterol screening in the elderly, 1989:
cost-benefit analysis of preimplantation genetic diagnosis for carrier couples of cystic fibrosis., A
Cost containment and financing the long--term care of the elderly
Cost-effectiveness analysis as a measure of value.
cost-effectiveness analysis of adjuvant trastuzumab regimens in early HER2/neu-positive breast cancer., A
Cost-effectiveness analysis of nephron sparing options for the management of small renal masses.
cost-effectiveness analysis of prescribing strategies in the management of gastroesophageal reflux disease., A
Cost-effectiveness and cost-benefit analysis of using methotrexate vs goeckerman therapy for psoriasis: A pilot study
Cost-effectiveness and evidence evaluation as criteria for coverage policy.
Cost-effectiveness of 3 methods to enhance the sensitivity of Papanicolaou testing
Cost effectiveness of alternative imaging strategies for the diagnosis of small-bowel Crohn's disease.
Cost-effectiveness of alternative test strategies for the diagnosis of coronary artery disease.
Cost-effectiveness of automated external defibrillators on airlines.
Cost-effectiveness of bypass surgery versus stenting in patients with multivessel coronary artery disease
Cost effectiveness of coronary heart disease prevention strategies in adults.
Cost-Effectiveness of Dabigatran Compared With Warfarin for Stroke Prevention in Atrial Fibrillation
Cost-effectiveness of defending against bioterrorism: a comparison of vaccination and antibiotic prophylaxis against anthrax.
Cost-effectiveness of recombinant human activated protein C and the influence of severity of illness in the treatment of patients with severe sepsis.
Cost-effectiveness of Screening BRCA1/2 Mutation Carriers With Breast Magnetic Resonance Imaging
Cost-effectiveness of screening for carotid stenosis in asymptomatic persons.
cost-effectiveness of therapy with teriparatide and alendronate in women with severe osteoporosis., The
Costs and benefits of prenatal screening for cystic fibrosis.
COSTS AND CONTROL OF ANTIBIOTIC RESISTANCE
Costs and health consequences of cholesterol screening for asymptomatic older Americans.
costs of decedents in the Medicare program: implications for payments to Medicare + Choice plans., The
Creating the costliest orphan. The Orphan Drug Act in the development of Ceredase.
Current approaches to cervical-cancer screening
Developing and testing a multimedia presentation of a health-state description.
discrete-time model of the acquisition of antibiotic-resistant infections in hospitalized patients., A
Does Comparative-Effectiveness Research Threaten Personalized Medicine?
Economic foundations of cost-effectiveness analysis
effect of assessment method and respondent population on utilities elicited for Gaucher disease., The
effect of geriatrics evaluation and management on nursing home use and health care costs: results from a randomized trial., The
Effect of Geriatrics Evaluation and Management on Nursing Home Use and Health Care Costs: Results Froma Randomized Trial, The
effect of search procedures on utility elicitations, The
Effectiveness and cost-effectiveness of expanded antiviral prophylaxis and adjuvanted vaccination strategies for an influenza A (H5N1) pandemic.
Effectiveness and cost-effectiveness of vaccination against pandemic influenza (H1N1) 2009.
Evaluating the federal role in financing health-related research.
Evidence-based coverage policy.
Evidence-Based Guidelines As A Foundation For Performance Incentives
Extracting subject demographic information from abstracts of randomized clinical trial reports.
Federal and private roles in the development and provision of alglucerase therapy for Gaucher disease
Following Your Heart or Your Head: Focusing on Emotions versus Information Differentially Influences the Decisions of Younger and Older Adults
Frontiers in health policy research 2
Frontiers in health policy research 3
Frontiers in health policy research 4
Frontiers in health policy research 6
Frontiers in health policy research 7
Future costs and the future of cost-effectiveness analysis.
Health care productivity
Health Outcomes and Costs of Community Mitigation Strategies for an Influenza Pandemic in the United States
Health plans' coverage determinations for technology-based interventions: the case of electrical bone growth stimulation.
How CER Could Pay for Itself -- Insights from Vertebral Fracture Treatments
How The Patient-Centered Outcomes Research Institute Can Best Influence Real-World Health Care Decision Making
Impacts of informal caregiver availability on long-term care expenditures in OECD countries.
Incidental extracardiac findings at coronary CT: clinical and economic impact.
Individualized cost-effectiveness analysis.
Influence of race on inpatient treatment intensity at the end of life.
Insurance and incentives for medical innovation
Invariance and inconsistency in utility ratings.
Is American health care uniquely inefficient?
Is Having More Preapproval Data The Best Way To Assure Drug Safety?
Is high-flux dialysis cost-effective?
Laparoscopy in women with unexplained infertility: a cost-effectiveness analysis.
Long-term care, wealth, and health of the disabled elderly living in the communty.
Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A cost-effectiveness analysis.
Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A meta-analysis of randomized, controlled trials.
Making the most of Pap testing
Management of Acute Kidney Injury in the Intensive Care Unit: A Cost-effectiveness Analysis of Daily vs Alternate-Day Hemodialysis
Measurement of the validity of utility elicitations performed by computerized interview.
Medical care at the end of life : diseases, treatment patterns, and costs
Menu without Prices, A
Modernizing Device Regulation
Mortality, hospital admissions, and medical costs of end-stage renal disease in the United States and Manitoba, Canada.
Multimedia quality of life assessment: advances with FLAIR.
multivariate analysis of mortality and hospital admissions with high-flux dialysis., A
New Technology Assessment, The
Nursing home discharges and exhaustion of medicare benefits
Perinatal screening for group B streptococci: cost-benefit analysis of rapid polymerase chain reaction.
Persistence of Medicare expenditures among elderly beneficiaries
PERSPECTIVE : Evidence-Based Guidelines As A Foundation For Performance Incentives Most guidelines are designed to guide better patient care but not to reward better clinical performance
PERSPECTIVE : To Use Technology Better
Polymerase chain reaction for the diagnosis of HIV infection in adults. A meta-analysis with recommendations for clinical practice and study design.
Population strategies to decrease sodium intake and the burden of cardiovascular disease: a cost-effectiveness analysis.
potential impact of comparative effectiveness research on U.S. health care expenditures., The
Practice Guidelines and Cholesterol Policy
Predicting nursing home utilization among the high-risk elderly
Price of Growth in the Medical-Device Industry, The
Problems with the report of the Expert Panel on blood cholesterol levels in children and adolescents.
Productivity costs, time costs and health-related quality of life: a response to the Erasmus Group
Promise Of Health Care Cost Containment, The
Quality of life assessment software for computer-inexperienced older adults: multimedia utility elicitation for activities of daily living.
Racial disparity in cardiac procedures and mortality among long-term survivors of cardiac arrest.
Realistic rigor in cost-effectiveness methods
resting electrocardiogram as a screening test. A clinical analysis., The
Rise of pay for performance: implications for care of people with chronic kidney disease.
Role Of Costs In Comparative Effectiveness Research, The
role of exercise testing in screening for coronary artery disease., The
Screening asymptomatic adults for cardiac risk factors: the serum cholesterol level.
Should we be measuring blood cholesterol levels in young adults?
Simple counts of ADL dependencies do not adequately reflect older adults' preferences toward states of functional impairment.
Systematic Review: The Effects of Growth Hormone on Athletic Performance
Systematic review: the safety and efficacy of growth hormone in the healthy elderly.
Technology Diffusion, Hospital Variation, and Racial Disparities Among Elderly Medicare Beneficiaries: 1989-2000.
To comfort always : the prospects of expanded social responsibility for long-term care
To use technology better.
Toward a 21st-century health care system: recommendations for health care reform.
Training synergies between medical informatics and health services research: successes and challenges.
Trends in hospital treatment of ventricular arrhythmias among Medicare beneficiaries, 1985 to 1995.
Trends in implantable cardioverter-defibrillator racial disparity: the importance of geography.
Trends in inpatient treatment intensity among Medicare beneficiaries at the end of life.
Triglyceride concentration and coronary heart disease.
U.S. Physician Workforce: Serious Questions Raised, Answers Needed, The
Uncertain Future for Cardiovascular Drug Development?, An
Unsupervised method for automatic construction of a disease dictionary from a large free text collection.
Unsupervised method for extracting machine understandable medical knowledge from a large free text collection.
Using cost-effectiveness analysis to target cholesterol reduction.
Utilization and outcomes of the implantable cardioverter defibrillator, 1987 to 1995.
Variation in health care spending, 2013:
Where to draw the line against cholesterol.
Willingness-to-pay utility assessment: feasibility of use in normative patient decision support systems.
Contributed to or performed: 
AMERICAN JOURNAL OF MEDICINE
ANNALS OF INTERNAL MEDICINE
HEALTH AFFAIRS -MILLWOOD VA THEN BETHESDA MA-
HEALTH SERVICES RESEARCH -CHICAGO-
NBER WORKING PAPER SERIES
NEW ENGLAND JOURNAL OF MEDICINE
Notes: 
Sources: 
BOWKER
HARV
NTA
ZETO